tirzepatide for obesity fda approval Approves Tirzepatide, A Potential Blockbuster Drug Type 2 Diabetes Tirzepatide (ZEPBOUND) Approved for Chronic
Description
helping users to more comprehensively improve their body shape and skin condition
These also support the cardiovascular benefits that tirzepatide provides
doi: 10.1056/NEJMoa2403664
Tirzepatide works on two hormone receptors (GIP + GLP-1) while semaglutide only targets GLP-1
